Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802982 · ClinicalTrials.gov registry record
Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates
A clinical trial of Neonatal Thrombocytopenia, sponsored by Boston Children's Hospital.
- Active
- Registry status
- 28
- Enrollment target
- 3
- Study locations
NCT02802982 is a study of Neonatal Thrombocytopenia that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 28 participants. The trial reports 3 study locations across 2 states.
The verdict
NCT02802982, a study of Neonatal Thrombocytopenia, is active but no longer recruiting, sponsored by Boston Children's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 28 participants
- Enrollment target
- 3
- Study locations
Study Summary
Parents of infants who have been thrombocytopenic for 3-4 days will be approached for consent to enter the study. For the purposes of the study, thrombocytopenia will be defined as a platelet count \<60,000/uL or a platelet count \<100,000/uL that prompted a platelet transfusion. Following enrollment, the platelet count will be followed in each infant. Participants will enter the study if on day 5 or later after the onset of thrombocytopenia (defined as above) infants either have a platelet count \<60,000/uL or a platelet count \<100,000/uL for which a platelet transfusion is ordered.
Conditions Studied
Study Locations (3)
Massachusetts
- Boston Children's Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Iowa
- The University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-04 |
| Est. Completion | 2024-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02802982
The ClinicalTrials.gov registry entry for NCT02802982 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neonatal Thrombocytopenia appearing as the primary indexed condition, and to 0 interventions.
NCT02802982 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Iowa.
Frequently Asked Questions
What is clinical trial NCT02802982 about?
NCT02802982 is a clinical study titled "Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates". Parents of infants who have been thrombocytopenic for 3-4 days will be approached for consent to enter the study. For the purposes of the study, thrombocytopenia will be defined as a platelet count \<60,000/uL or a platelet count \<100,000/uL that prompted a platelet transfusion. Following enrollmen...
What is the current status of trial NCT02802982?
This trial is currently active not recruiting. The enrollment target is 28 participants. The study started on 2013-04. Estimated completion is 2024-12.
What conditions does trial NCT02802982 study?
This clinical trial studies the following conditions: Neonatal Thrombocytopenia.
Who is sponsoring clinical trial NCT02802982?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02802982 being conducted?
This trial has 3 study locations across Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neonatal Thrombocytopenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.